CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Changzhou Qianhong Biopharma Co., Ltd. Company Snapshot
Changzhou Qianhong Biopharma Co., Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Changzhou Qianhong Biopharma Co., Ltd. with three other companies in this sector in China: Shenzhen Neptunus Interlong Bio-technique Co Ltd (2016 sales of 759.11 million Chinese Renmimbi [US$110.25 million] of which 57% was Manufacturing & selling medicine product), Jiangxi Fuxiang Pharmaceutical Co Ltd (763.68 million Chinese Renmimbi [US$110.92 million] of which 100% was Pharmaceutical manufacturing industry), and Shanxi C&Y Pharmaceutical Group Co Ltd (745.95 million Chinese Renmimbi [US$108.34 million] of which 74% was Pharmaceutical Manufacturing).

Sales Analysis. During the year ended December of 2016, sales at Changzhou Qianhong Biopharma Co., Ltd. were 776.38 million Chinese Renmimbi (US$112.76 million). This is an increase of 2.6% versus 2015, when the company's sales were 757.02 million Chinese Renmimbi. Despite this increase, sales are still below the level achieved in 2014, when Changzhou Qianhong Biopharma Co., Ltd. reported sales of 814.58 million Chinese Renmimbi. The sales level in 2016 was fairly close to the level five years ago: in 2011, Changzhou Qianhong Biopharma Co., Ltd. had sales of 737.65 million Chinese Renmimbi. Sales of Bio-Pharmaceutical Industry saw an increase of 2.6% in 2016, from 756.44 million Chinese Renmimbi to 775.85 million Chinese Renmimbi. Not all segments of Changzhou Qianhong Biopharma Co., Ltd. experienced an increase in sales in 2016: sales of Other Operations fell 11.9% to 538,105.87 Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Changzhou Qianhong Biopharma Co., Ltd.
  Stock Performance Chart for Changzhou Qianhong Biopharma Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 6.20
(Figures in Chinese Renmimbi)
1 Week 1.5%   13 Weeks -3.7%  
4 Weeks -8.3%   52 Weeks -24.7%  
 
Changzhou Qianhong Biopharma Co., Ltd. Key Data:
  Ticker: 002550 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 776,376,216
(Year Ending Jan 2017).
Employees: 1,110
  Currency: Chinese Renmimbi Market Cap: 7,936,000,000
  Fiscal Yr Ends: December Shares Outstanding: 1,280,000,000
  Share Type: Gu A Closely Held Shares: 588,394,962
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.